Winton Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-82,256
| Closed | -$5.16M | – | 1200 |
|
|
2026
Q1 | $5.16M | Sell |
82,256
-69,197
| -46% | -$5.54M | 0.18% | 157 |
|
|
2025
Q4 | $14.4M | Buy |
151,453
+3,711
| +3% | +$364K | 0.5% | 30 |
|
|
2025
Q3 | $14.4M | Buy |
+147,742
| New | +$15.3M | 0.54% | 29 |
|
|
2025
Q2 | – | Sell |
-21,937
| Closed | -$2.21M | – | 837 |
|
|
2025
Q1 | $2.21M | Sell |
21,937
-34,209
| -61% | -$3.44M | 0.13% | 172 |
|
|
2024
Q4 | $5.01M | Sell |
56,146
-5,240
| -9% | -$461K | 0.33% | 90 |
|
|
2024
Q3 | $5.14M | Buy |
61,386
+55,101
| +877% | +$4.34M | 0.36% | 77 |
|
|
2024
Q2 | $484K | Buy |
+6,285
| New | +$460K | 0.03% | 427 |
|
|
2023
Q4 | – | Sell |
-71,828
| Closed | -$3.79M | – | 747 |
|
|
2023
Q3 | $3.79M | Sell |
71,828
-47,892
| -40% | -$2.51M | 0.31% | 52 |
|
|
2023
Q2 | $6.48M | Buy |
119,720
+89,352
| +294% | +$4.67M | 0.54% | 31 |
|
|
2023
Q1 | $1.52M | Sell |
30,368
-20,374
| -40% | -$960K | 0.09% | 293 |
|
|
2022
Q4 | $2.35M | Buy |
+50,742
| New | +$2.2M | 0.15% | 172 |
|
|
2021
Q4 | – | Sell |
-18,780
| Closed | -$815K | – | 1054 |
|
|
2021
Q3 | $815K | Buy |
+18,780
| New | +$831K | 0.05% | 606 |
|
|
2019
Q4 | – | Sell |
-105,606
| Closed | -$4.3M | – | 1560 |
|
|
2019
Q3 | $4.3M | Buy |
105,606
+90,055
| +579% | +$3.82M | 0.05% | 360 |
|
|
2019
Q2 | $668K | Sell |
15,551
-15,119
| -49% | -$582K | 0.01% | 562 |
|
|
2019
Q1 | $1.18M | Buy |
30,670
+1,141
| +4% | +$43.6K | 0.02% | 321 |
|
|
2018
Q4 | $1.04M | Buy |
29,529
+10,556
| +56% | +$383K | 0.02% | 341 |
|
|
2018
Q3 | $730K | Sell |
18,973
-805
| -4% | -$28.1K | 0.02% | 484 |
|
|
2018
Q2 | $647K | Sell |
19,778
-37,555
| -66% | -$1.13M | 0.02% | 548 |
|
|
2018
Q1 | $1.57M | Sell |
57,333
-46,489
| -45% | -$1.26M | 0.04% | 377 |
|
|
2017
Q4 | $2.57M | Sell |
103,822
-1,369
| -1% | -$37.8K | 0.07% | 351 |
|
|
2017
Q3 | $3.07M | Buy |
+105,191
| New | +$2.91M | 0.1% | 232 |
|
|
2016
Q3 | – | Sell |
-29,720
| Closed | -$695K | – | 384 |
|
|
2016
Q2 | $695K | Buy |
+29,720
| New | +$643K | 0.01% | 283 |
|
|
2016
Q1 | – | Sell |
-12,244
| Closed | -$226K | – | 316 |
|
|
2015
Q4 | $226K | Sell |
12,244
-337,877
| -97% | -$6.05M | ﹤0.01% | 312 |
|
|
2015
Q3 | $5.75M | Buy |
+350,121
| New | +$5.98M | 0.05% | 331 |
|
|
2014
Q4 | – | Sell |
-470,215
| Closed | -$5.55M | – | 621 |
|
|
2014
Q3 | $5.55M | Sell |
470,215
-751,253
| -62% | -$9.46M | 0.04% | 374 |
|
|
2014
Q2 | $15.6M | Buy |
+1,221,468
| New | +$15.9M | 0.11% | 300 |
|
Other funds holding BSX
Winton Group's BSX Position: Q2 2026 in Review
Winton Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 82,256 shares — an estimated $5.16M sold.
Winton Group first reported a position in BSX in Q2 2014 and held it in 26 quarters. The position peaked at $15.6M in Q2 2014. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Winton Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
- Winton Group sold 82,256 Boston Scientific shares in Q2 2026, an estimated $5.16M.
- Winton Group first reported a position in Boston Scientific in Q2 2014 and held it in 26 quarters.
- Winton Group's Boston Scientific position peaked at $15.6M in Q2 2014.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.